Cargando…

Organotypic spinal cord cultures: An in vitro 3D model to preliminary screen treatments for spinal muscular atrophy

Spinal muscular atrophy (SMA) is a severe neuromuscular disease affecting children, due to mutation/deletion of survival motor neuron 1 (SMN1) gene. The lack of functional protein SMN determines motor neuron (MN) degeneration and skeletal muscle atrophy, leading to premature death due to respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boido, Marina, De Amicis, Elena, Mareschi, Katia, Fagioli, Franca, Vercelli, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586821/ https://www.ncbi.nlm.nih.gov/pubmed/34734684 http://dx.doi.org/10.4081/ejh.2021.3294

Ejemplares similares

Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2016)

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2018)

Inhibition of autophagy delays motoneuron degeneration and extends lifespan in a mouse model of spinal muscular atrophy
por: Piras, Antonio, et al.
Publicado: (2017)

Pharmacological c-Jun NH(2)-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice
por: Schellino, Roberta, et al.
Publicado: (2018)

Genes and miRNAs as Hurdles and Promoters of Corticospinal Tract Regeneration in Spinal Cord Injury
por: Boido, Marina, et al.
Publicado: (2021)

JNK Signaling Pathway Involvement in Spinal Cord Neuron Development and Death
por: Schellino, Roberta, et al.
Publicado: (2019)

Autophagy inhibition: a new therapeutic target in spinal muscular atrophy
por: Piras, Antonio, et al.
Publicado: (2018)

Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
por: Menduti, Giovanna, et al.
Publicado: (2020)

Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice
por: Boido, Marina, et al.
Publicado: (2023)

Growth patterns in children with spinal muscular atrophy
por: De Amicis, Ramona, et al.
Publicado: (2021)

Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice
por: Galbiati, Mariarita, et al.
Publicado: (2023)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Myogenic Potential of Whole Bone Marrow Mesenchymal Stem Cells In Vitro and In Vivo for Usage in Urinary Incontinence
por: Gunetti, Monica, et al.
Publicado: (2012)

Magnetic resonance imaging of the cervical spinal cord in spinal muscular atrophy
por: Stam, Marloes, et al.
Publicado: (2019)

Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy
por: Cofano, Fabio, et al.
Publicado: (2019)

The Organotypic Longitudinal Spinal Cord Slice Culture for Stem Cell Study
por: Sypecka, Joanna, et al.
Publicado: (2015)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Spinal Muscular Atrophy Diagnosed by Newborn Screening
por: Lopez-Chacon, Matias, et al.
Publicado: (2019)

Organotypic Spinal Cord Slice Culture to Study Neural Stem/Progenitor Cell Microenvironment in the Injured Spinal Cord
por: Kim, Hyuk Min, et al.
Publicado: (2010)

Interventions for spinal muscular atrophy: an impetus for newborn screening
Publicado: (2021)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Selective Vulnerability of Spinal and Cortical Motor Neuron Subpopulations in delta7 SMA Mice
por: d’Errico, Paolo, et al.
Publicado: (2013)

Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
por: Jędrzejowska, Maria
Publicado: (2020)

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
por: Kimizu, Tomokazu, et al.
Publicado: (2021)

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
por: Weidlich, Diana, et al.
Publicado: (2023)

First Use of Non-Invasive Spinal Cord Stimulation in Motor Rehabilitation of Children with Spinal Muscular Atrophy
por: Novikov, Anton, et al.
Publicado: (2023)

Spinal Muscular Atrophy, types I and II: What are the differences in body composition and resting energy expenditure?
por: Bertoli, Simona, et al.
Publicado: (2017)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Longitudinal characterization of biomarkers for spinal muscular atrophy
por: Bonati, Ulrike, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d8p9btp855a118rd8j744f7usr